BRNS
Barinthus Biotherapeutics
BRNS
BRNS
16 hedge funds and large institutions have $10.3M invested in Barinthus Biotherapeutics in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
-3
Holders Change %
-15.79%
% of All Funds
0.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
1
Increased
2
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$8.7K |
| 2 |
Millennium Management
New York
|
+$974 |
Top Sellers
| 1 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$646K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$34.1K |
| 3 |
CCG
Catalina Capital Group
Torrance,
California
|
-$12.4K |
| 4 |
BlackRock
New York
|
-$7.72K |
| 5 |
IIM
Ipswich Investment Management
Beverly,
Massachusetts
|
-$6.04K |
